ME Therapeutics Holdings Inc
F:Q9T
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ME Therapeutics Holdings Inc
F:Q9T
|
CA |
|
E
|
EVN AG
SWB:EVN
|
AT |
|
F
|
First Hydrogen Corp
XTSX:FHYD
|
CA |
|
S
|
SAP SE
XMUN:SAP
|
DE |
|
P
|
Pulmatrix Inc
F:2PU1
|
US |
|
Raymond Ltd
NSE:RAYMOND
|
IN |
|
Bridgewater Bancshares Inc
NASDAQ:BWB
|
US |
|
electroCore, Inc.
NASDAQ:ECOR
|
US |
|
Rivian Automotive Inc
F:99U
|
US |
|
Sands China Ltd
F:599
|
MO |
|
T
|
Thales SA
OTC:THLLY
|
FR |
|
NTG Nordic Transport Group AS
CSE:NTG
|
DK |
|
American Express Co
NYSE:AXP
|
US |
Shareholder Yield
Current shareholder yield for Q9T is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Q9T Price
ME Therapeutics Holdings Inc
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -63% |
| Market Capitalization | 59.8m EUR |
| Shares Outstanding | 29 590 000 |
| Percentage of Shares Shorted |
N/A
|
